M42 is partnering with the Broad Institute, Microsoft, and the International Center for Genetic Disease to enhance clinico-genomic data access and research using the Terra platform.

The collaboration will create the Global Life Sciences Platform on Terra, aimed at supporting precision medicine and life science strategies in the UAE and worldwide.

M42's platform will be built on Microsoft Azure Health Data Services and employ generative AI for analytics and interoperability in research and clinical care.

The initiative includes the development of a Trusted Research Environment for secure life science research data access.

With over 500,000 whole genome sequences completed, M42's project is one of the largest population genomic efforts globally.

The partnership is a strategic move to enhance M42's data science capabilities and clinico-genomic infrastructure, with the potential to expedite global research and drug discovery.

The collaboration seeks to increase Middle Eastern representation in genomic studies, contributing to the diversity of global research.

M42 is committed to delivering proactive health solutions and transforming global health through innovative clinical solutions and partnerships.